Global Biopharmaceutical Logistics Market Overview:
The biopharmaceutical industry is attractive because of the cost benefits and continuous medical innovation. The highest spending is done by the United States government of the biopharmaceutical industry. Across the globe, there is an increasing number of research and development which enhance drug discovery. The biopharmaceutical industry is helping the way in developing vaccines and treatment for COVID-19. In today's market situation biopharmaceutical manufacturers are working on phase 1 studies for vaccines and treatment. Biomedical innovation is life-threatening to addressing human health challenges. With the development of life sciences, the innovation system depends on robust public and private funding of biomedical R&D. With the increasing government support for biomedical innovation is defended in part on the grounds that is used by a wide range of innovators. Some of the key players profiled in the study are FedEx Corporation (United States), Ceva Logistics LLC (Switzerland), Amerisource Bergen Corporation (United States), Panalpina Group (Switzerland), Kuehne + Nagel International AG (Switzerland), XPO Logistics, Inc (United States), United Parcel Service, Inc (United States), Deutsche Post DHL Group (Germany), DB Schenker (Germany) and C.H. Robinson Worldwide (United States).
On the basis of geography, the market of Biopharmaceutical Logistics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Shipping, the sub-segment i.e. Air Shipping will boost the Biopharmaceutical Logistics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Component, the sub-segment i.e. Storage will boost the Biopharmaceutical Logistics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Offerings, the sub-segment i.e. Software will boost the Biopharmaceutical Logistics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Development in Biosimilars Market
- Growing Demand for Biological Treatment from Chronic Diseases Including Diabetes and Cancer
- In Biosimilar Market Companies Are Facing Cost Declining Market, And Increasing Competition
- Increasing Number of Public and Private Partnership, Because of the Growing Interest Brazilian Health System
- Increase in Market Competency
- Increasing Number of Launches by the Leading Industry Players
- Biosimilars are Expecting a Huge Role in the Pharmaceutical Market in the Coming Years. The Major Reason Behind its Adoption is Cost-Saving, Biological Treatment Attainability
- Variation in Regulation
- High Complexity of Manufacturing
Major Market Developments:
In Jun 2020, Sumitovant Biopharma Ltd. announced an agreement with Sunovion pharmaceuticals. Under this agreement, the company provides services including account management, contract management, and others. Through these initiatives, the company will become more competitive in the coming years.
The market is seeing strong rivalry among market players, this market is having huge growth. The key leading vendors are highly focusing on production technologies, efficiency enhancement, and product life. There is a various growth opportunity in this market which is captured by market-leading players through tracking the ongoing process enhancement and huge invest in market growth strategies.
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analyst and Strategic Business Planners, Biopharmaceuticals Logistics Providers, Government Regulatory and Research Organizations and End-Use Industries
Major Objectives Focused through this Study
To define, describe, and forecast the Global Biopharmaceutical Logistics market on the basis of product [Cold Chain Logistics and Non-Cold Chain Logistics] , application , key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Biopharmaceutical Logistics market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Biopharmaceutical Logistics industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are BioPharma Logistics (Belgium), Cavalier Logistics (United States) and Yourway (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Biopharmaceutical Logistics market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.